Money Concepts Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-23,110
Closed -$282K – 368
2023
Q1
$282K Buy
23,110
+19,501
+540% +$604K 0.02% 361
2022
Q4
$102K Buy
3,609
+1,947
+117% +$61.8K ﹤0.01% 952
2022
Q3
$55K Sell
1,662
-3
-0.2% -$110 ﹤0.01% 695
2022
Q2
$55K Sell
1,665
-4,623
-74% -$162K ﹤0.01% 681
2022
Q1
$289K Buy
6,288
+4,143
+193% +$198K 0.02% 592
2021
Q4
$131K Buy
+2,145
New +$148K 0.01% 527
2021
Q1
$907K Sell
10,219
-1,358
-12% -$135K 0.07% 223
2020
Q4
$1.08M Buy
+11,577
New +$922K 0.1% 175

Other funds holding ARKG

Money Concepts Capital's ARKG Position: Q2 2023 in Review

Money Concepts Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 23,110 shares — an estimated $282K sold.

Money Concepts Capital first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $1.08M in Q4 2020. 292 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

  • Money Concepts Capital reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
  • Money Concepts Capital sold 23,110 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $282K.
  • Money Concepts Capital first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
  • Money Concepts Capital's ARK Genomic Revolution ETF position peaked at $1.08M in Q4 2020.
  • 292 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Money Concepts Capital's 13F filing for Q2 2023, filed 1 Aug 2023.